{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:40:09Z","timestamp":1779302409816,"version":"3.51.4"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2003,12,30]],"date-time":"2003-12-30T00:00:00Z","timestamp":1072742400000},"content-version":"vor","delay-in-days":697,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,2]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Patients with primary biliary cirrhosis (PBC) may have additional features of autoimmune hepatitis (AIH). Corticosteroids usually contraindicated in PBC have been advocated for these patients. Patients with antimitochondrial antibody (AMA)-positive PBC from two previous randomized, controlled trials were assessed for features of AIH. Their biochemical, immunologic, and histologic responses to ursodeoxycholic acid (UDCA) versus placebo were compared with those without AIH features. The survival of patients testing positive or negative for antinuclear antibodies (ANA) was also examined. Features of AIH were defined by the presence of 2 or more of the following: 1) alanine transaminase (ALT) &gt; 5\u00d7 the upper limit of normal (ULN); 2) immunoglobulin G (IgG) &gt; 2\u00d7 ULN or positive anti-smooth muscle antibody (ASMA); and 3) moderate to severe lobular inflammation on pretreatment liver biopsy. Testing for AMA, ASMA, and ANA was done by immunofluorescence. The change in serum bilirubin, alkaline phosphatase (ALP), transaminases, IgM, and IgG from baseline to 2 years was compared. Of the 331 patients randomized, 16 (4.8%) had features of AIH (12 UDCA, 4 placebo). The median percent change in serum biochemistry and immunoglobulin values were similar in patients with PBC \u00b1 features of AIH after 2 years of therapy with UDCA. Over 2 years, little change in histologic features of AIH was observed. Survival was similar for patients with PBC with and without ANA. In conclusion, features of AIH in PBC may be transient and response to UDCA therapy similar to patients with PBC without features of AIH.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1053\/jhep.2002.30902","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T03:46:10Z","timestamp":1030247170000},"page":"409-413","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":150,"title":["Primary biliary cirrhosis with additional features of autoimmune hepatitis: Response to therapy with ursodeoxycholic acid"],"prefix":"10.1097","volume":"35","author":[{"given":"Supriya","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Cauch-Dudek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian R.","family":"Wanless","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith D.","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Batts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny E.","family":"Heathcote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1053\/jhep.2002.30902-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","article-title":"Primary biliary cirrhosis","volume":"335","author":"Kaplan","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/jhep.2002.30902-BIB2|cit2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/s-2008-1040584","article-title":"New concepts in biliary cirrhosis","volume":"7","author":"Ludwig","year":"1987","journal-title":"Semin Liver Dis"},{"key":"10.1053\/jhep.2002.30902-BIB3|cit3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0046-8177(93)90085-U","article-title":"Necroinflammatory changes in hepatic lobules in primary biliary cirrhosis with less well-defined cholestatic changes","volume":"24","author":"Nakanuma","year":"1993","journal-title":"Hum Pathol"},{"key":"10.1053\/jhep.2002.30902-BIB4|cit4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199604043341406","article-title":"Autoimmune hepatitis","volume":"334","author":"Krawitt","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/jhep.2002.30902-BIB5|cit5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.30902-BIB6|cit6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.30902-BIB7|cit7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis","volume":"40","author":"Cook","year":"1971","journal-title":"Q J Med"},{"key":"10.1053\/jhep.2002.30902-BIB8|cit8","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1053\/jhep.2002.30902-BIB9|cit9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis","volume":"1","author":"Murray-Lyon","year":"1973","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.30902-BIB10|cit10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hep.1840100418","article-title":"Prednisolone for primary biliary cirrhosis-good news, bad news","volume":"10","author":"Combes","year":"1989","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.30902-BIB11|cit11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.510310209","article-title":"Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholc acid","volume":"31","author":"Angulo","year":"2000","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.30902-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals","volume":"29","author":"Lohse","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.30902-BIB13|cit13","first-page":"A1276","article-title":"High titers of anti-nuclear antibodies in patients with primary biliary cirrhosis mean better prognosis [Abstract]","volume":"116","author":"Shimuzu","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/jhep.2002.30902-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","article-title":"The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"19","author":"Heathcote","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.30902-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis","volume":"106","author":"Lindor","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/jhep.2002.30902-BIB16|cit16","first-page":"71","volume-title":"Manual of Clinical Laboratory Immunology","author":"Check","year":"1992"},{"key":"10.1053\/jhep.2002.30902-BIB17|cit17","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/jhep.2002.30902-BIB18|cit18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"J Hepatol"},{"key":"10.1053\/jhep.2002.30902-BIB19|cit19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1440-1746.1998.tb00674.x","article-title":"Efficacy of ursodeoxycholic acid in Japanese patients with type-1 autoimmune hepatitis","volume":"13","author":"Nakamura","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/jhep.2002.30902-BIB20|cit20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Heathcote","year":"1999","journal-title":"J Hepatol"},{"key":"10.1053\/jhep.2002.30902-BIB21|cit21","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-125-7-199610010-00009","article-title":"Review: the variant forms of autoimmune hepatitis","volume":"125","author":"Czaja","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1053\/jhep.2002.30902-BIB22|cit22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0016-5085(94)94899-2","article-title":"Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid","volume":"106","author":"Jazrawi","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/jhep.2002.30902-BIB23|cit23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0016-5085(97)70239-7","article-title":"Bile acid concentration in human and rat liver tissue and in hepatocyte nuclei","volume":"112","author":"Setchell","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/jhep.2002.30902-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1172\/JCI1325","article-title":"A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation","volume":"101","author":"Rodrigues","year":"1998","journal-title":"J Clin Invest"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1053%2Fjhep.2002.30902","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1053%2Fjhep.2002.30902","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200202000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T15:54:09Z","timestamp":1738943649000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200202000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002]]}},"URL":"https:\/\/doi.org\/10.1053\/jhep.2002.30902","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}